Martin Gertsch
Chairman bei Artidis AG
Profil
Martin Gertsch is currently the Chairman at Artidis AG, Director at the University of Basel, and Director at Centro Universitário da FEI.
He previously held the position of Vice Chairman at Santhera Pharmaceuticals Holding AG from 2017 to 2021.
He also served as Director at Symetis SA, Evolva Holding SA, Acino International AG, Synthes, Inc., and Acino Pharma AG.
Mr. Gertsch was the Chief Financial Officer at Acino International AG from 2013 to 2014 and at Cell Medica Switzerland AG from 2009 to 2010.
He was also the Head-Finance EMEA Region at Synthes, Inc. and the Vice President & Head-EMEA Finance at DePuy Synthes, Inc. Prior to that, he worked as the Chief Financial Officer at Straumann Holding AG from 2002 to 2006 and as the Chief Financial Officer at ESBATech AG from 2007 to 2009.
Mr. Gertsch started his career as an Audit Engagement Manager at PricewaterhouseCoopers, Inc. from 1986 to 1997.
Aktive Positionen von Martin Gertsch
| Unternehmen | Position | Beginn |
|---|---|---|
| Centro Universitário da FEI | Director/Board Member | - |
| University of Basel | Director/Board Member | - |
Artidis AG
 Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Chairman | - |
Ehemalige bekannte Positionen von Martin Gertsch
| Unternehmen | Position | Ende |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Chairman | 04.04.2017 |
| SYMETIS SA | Director/Board Member | 01.06.2017 |
| ACINO HOLDING AG | Director of Finance/CFO | 14.01.2014 |
Acino Pharma AG
 Acino Pharma AG Pharmaceuticals: MajorHealth Technology Acino Pharma AG engages in the development, production, and distribution of chemical and pharmaceutical products. It also acquires, manages, and sells participating interests in firms, real estate, and intellectual property rights. The company was founded in 1961 and is headquartered in Liesberg, Switzerland. | Director of Finance/CFO | 01.01.2014 |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Director of Finance/CFO | 01.01.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| STRAUMANN HOLDING AG | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| EVOLVA HOLDING SA | Consumer Non-Durables |
| Private Unternehmen | 9 |
|---|---|
Acino International AG
 Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Synthes, Inc.
 Synthes, Inc. Medical SpecialtiesHealth Technology Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland. | Health Technology |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |
Symetis SA
 Symetis SA BiotechnologyHealth Technology Symetis SA develops minimally invasive heart valve replacement devices. Its products include ACURATE TA and ACURATE neo. The company was founded by Simon P. Hoerstrup and Gregor Zünd on September 5, 2001 and is headquartered in Ecublens, Switzerland. | Health Technology |
PricewaterhouseCoopers, Inc.
 PricewaterhouseCoopers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers, Inc. is a South African company that provides accounting, auditing, and bookkeeping services. The private company is based in Sunninghill, South Africa. | Commercial Services |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Health Technology |
Acino Pharma AG
Acino Pharma AG Pharmaceuticals: MajorHealth Technology Acino Pharma AG engages in the development, production, and distribution of chemical and pharmaceutical products. It also acquires, manages, and sells participating interests in firms, real estate, and intellectual property rights. The company was founded in 1961 and is headquartered in Liesberg, Switzerland. | Health Technology |
DePuy Synthes, Inc.
 DePuy Synthes, Inc. Medical SpecialtiesHealth Technology The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN. | Health Technology |
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Health Technology |
